Inside Precision Medicine December 5, 2024
Malorye Branca

Personalized medicine is continuing to take hold, according to the first-ever annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) Cancer Programs. Among the key findings was that more cancers are being treated with targeted medical therapies before surgery. The report also describes in-depth data on breast, colorectal, and pancreatic cancer, each of which are on the rise among young people.

The NCDB is a clinical oncology database jointly operated by the ACS and the American Cancer Society. It captures hospital-based data on approximately 74% of all cancers diagnosed in the U.S. and is one of the most comprehensive cancer research databases. The findings were published this week in the Journal of the American...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Precision Medicine, Survey / Study, Trends
Oncologist talks personalized medicine for pancreatic cancer
AI offers a step above genomic solutions
How Mayo Clinic is using real-world data to advance precision medicine
Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI
Behind The Breakthroughs: Carrying Medicine Into the Post-Moore’s Law Era

Share This Article